Market price today
Regenicin, Inc. (RGIN) Stock Price & Analysis
Gross Profit Margin
Operating Profit Margin
Net Profit Margin
Return on Assets
Return on Equity
Return on Capital Employed
Company general description and statistics
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
Return on Investments
Frequently Asked Question
How many company shares are outstanding in 2023?
There are stock number shares outstanding of Regenicin, Inc. (RGIN) on the PNK in 2023.
What is P/E ratio of enterprise in 2023?
The current P/E ratio of enterprise is -0.081 in 2023.
What is the ticker symbol of Regenicin, Inc. stock?
The ticker symbol of Regenicin, Inc. stock is RGIN.
What is company IPO date?
IPO date of Regenicin, Inc. is 2009-11-16.
What is company current share price?
Current share price is 0.001 USD.
What is stock market cap today?
The market cap of stock today is 76742.000.
What is PEG ratio in 2023?
The current 0.002 is 0.002 in 2023.
What is the number of employees in 2023?
In 2023 the company has 3.